Sarepta Therapeutics - 24 Year Stock Price History | SRPT

Historical daily share price chart and data for Sarepta Therapeutics since 1997 adjusted for splits. The latest closing stock price for Sarepta Therapeutics as of September 23, 2021 is 90.54.
  • The all-time high Sarepta Therapeutics stock closing price was 178.74 on December 22, 2020.
  • The Sarepta Therapeutics 52-week high stock price is 181.83, which is 100.8% above the current share price.
  • The Sarepta Therapeutics 52-week low stock price is 65.30, which is 27.9% below the current share price.
  • The average Sarepta Therapeutics stock price for the last 52 weeks is 99.15.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Sarepta Therapeutics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2021 81.3107 165.2900 168.9500 65.9700 90.5400 -46.89%
2020 137.8229 129.0900 178.7400 82.3800 170.4900 32.12%
2019 117.1305 107.5000 156.9100 72.8100 129.0400 18.24%
2018 105.9535 58.2500 161.5100 54.0200 109.1300 96.14%
2017 39.1454 27.9200 56.7500 27.6700 55.6400 102.84%
2016 26.6381 38.0700 62.3500 10.7400 27.4300 -28.90%
2015 25.1902 14.9400 41.7900 11.6100 38.5800 166.62%
2014 24.1064 20.5800 38.9100 12.6000 14.4700 -28.96%
2013 33.2875 26.2400 53.8100 12.8900 20.3700 -21.05%
2012 11.8636 4.4391 44.9300 3.4600 25.8000 477.30%
2011 8.6925 13.0174 15.4769 3.2394 4.4691 -64.86%
2010 10.0136 9.4781 13.0774 6.8986 12.7175 45.21%
2009 8.0019 4.0792 14.8170 3.2999 8.7582 121.88%
2008 7.1241 8.5183 11.2777 2.8794 3.9472 -53.33%
2007 16.1664 18.5363 19.1962 7.8584 8.4583 -55.66%
2006 28.7640 20.3359 51.8896 15.4769 19.0762 -7.83%
2005 15.9863 13.4973 24.8356 11.9976 20.6959 46.81%
2004 16.0161 24.4751 28.4943 9.5381 14.0972 -42.26%
2003 29.1049 29.2142 42.2915 12.2376 24.4151 -18.60%
2002 37.5241 66.2268 77.8044 16.1908 29.9940 -54.21%
2001 44.1330 25.8728 67.1266 17.9964 65.5069 129.89%
2000 61.9206 34.4931 157.1086 24.3731 28.4943 -12.65%
1999 23.7910 24.3731 43.4913 15.3749 32.6215 35.95%
1998 32.6416 40.8698 45.9268 16.4967 23.9952 -41.82%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $6.984B $0.540B
Sarepta Therapeutics, Inc. focuses on the discovery and development of RNA-based therapeutics for the treatment of rare and infectious diseases. The Company's diverse pipeline includes its lead program eteplirsen, for Duchenne muscular dystrophy. Sarepta Therapeutics, Inc., formerly known as AVI BioPharma, Inc., is headquartered in Bothell, Washington.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $133.660B 8.90
Bio-Rad Laboratories (BIO.B) United States $23.483B 50.05
QIAGEN (QGEN) Netherlands $12.482B 21.14
Biohaven Pharmaceutical Holding (BHVN) United States $8.764B 0.00
Emergent Biosolutions (EBS) United States $2.892B 6.98
Arcus Biosciences (RCUS) United States $2.573B 0.00
Myovant Sciences (MYOV) United Kingdom $2.051B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.021B 0.00
Zymeworks (ZYME) Canada $1.443B 0.00
Ambrx Biopharma (AMAM) United States $0.527B 0.00
SQZ Biotechnologies (SQZ) United States $0.417B 0.00
Enzo Biochem (ENZ) United States $0.172B 50.71